208 related articles for article (PubMed ID: 25563413)
1. Advances in the molecular functions of syndecan-1 (SDC1/CD138) in the pathogenesis of malignancies.
Gharbaran R
Crit Rev Oncol Hematol; 2015 Apr; 94(1):1-17. PubMed ID: 25563413
[TBL] [Abstract][Full Text] [Related]
2. Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.
Nikolova V; Koo CY; Ibrahim SA; Wang Z; Spillmann D; Dreier R; Kelsch R; Fischgräbe J; Smollich M; Rossi LH; Sibrowski W; Wülfing P; Kiesel L; Yip GW; Götte M
Carcinogenesis; 2009 Mar; 30(3):397-407. PubMed ID: 19126645
[TBL] [Abstract][Full Text] [Related]
3. Syndecan-1 regulates adipogenesis: new insights in dedifferentiated liposarcoma tumorigenesis.
Zaragosi LE; Dadone B; Michiels JF; Marty M; Pedeutour F; Dani C; Bianchini L
Carcinogenesis; 2015 Jan; 36(1):32-40. PubMed ID: 25344834
[TBL] [Abstract][Full Text] [Related]
4. Targeting syndecan-1: new opportunities in cancer therapy.
Yang Z; Chen S; Ying H; Yao W
Am J Physiol Cell Physiol; 2022 Jul; 323(1):C29-C45. PubMed ID: 35584326
[TBL] [Abstract][Full Text] [Related]
5. Targeting of syndecan-1 by micro-ribonucleic acid miR-10b modulates invasiveness of endometriotic cells via dysregulation of the proteolytic milieu and interleukin-6 secretion.
Schneider C; Kässens N; Greve B; Hassan H; Schüring AN; Starzinski-Powitz A; Kiesel L; Seidler DG; Götte M
Fertil Steril; 2013 Mar; 99(3):871-881.e1. PubMed ID: 23206733
[TBL] [Abstract][Full Text] [Related]
6. Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine.
Akl MR; Nagpal P; Ayoub NM; Prabhu SA; Gliksman M; Tai B; Hatipoglu A; Goy A; Suh KS
Oncotarget; 2015 Oct; 6(30):28693-715. PubMed ID: 26293675
[TBL] [Abstract][Full Text] [Related]
7. Mapping the Interactome of the Nuclear Heparan Sulfate Proteoglycan Syndecan-1 in Mesothelioma Cells.
Kumar-Singh A; Shrinet J; Parniewska MM; Fuxe J; Dobra K; Hjerpe A
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32664515
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor α regulates the expression of syndecan-1 in human breast carcinoma cells.
Fleurot E; Goudin C; Hanoux V; Bonnamy PJ; Levallet J
Endocr Relat Cancer; 2019 Jun; 26(6):615-628. PubMed ID: 30978702
[TBL] [Abstract][Full Text] [Related]
9. Irradiation-induced angiogenesis is associated with an MMP-9-miR-494-syndecan-1 regulatory loop in medulloblastoma cells.
Asuthkar S; Velpula KK; Nalla AK; Gogineni VR; Gondi CS; Rao JS
Oncogene; 2014 Apr; 33(15):1922-33. PubMed ID: 23728345
[TBL] [Abstract][Full Text] [Related]
10. Syndecan-1 (CD138) contributes to prostate cancer progression by stabilizing tumour-initiating cells.
Shimada K; Anai S; Fujii T; Tanaka N; Fujimoto K; Konishi N
J Pathol; 2013 Dec; 231(4):495-504. PubMed ID: 24549646
[TBL] [Abstract][Full Text] [Related]
11. Role of syndecan-1 and exogenous heparin in hepatoma sphere formation.
Lin SC; Wu CP; Tseng T; Jhang Y; Lee SC
Biochem Cell Biol; 2020 Apr; 98(2):112-119. PubMed ID: 31042409
[TBL] [Abstract][Full Text] [Related]
12. Syndecan-1 knockdown inhibits glioma cell proliferation and invasion by deregulating a c-src/FAK-associated signaling pathway.
Shi S; Zhong D; Xiao Y; Wang B; Wang W; Zhang F; Huang H
Oncotarget; 2017 Jun; 8(25):40922-40934. PubMed ID: 28422726
[TBL] [Abstract][Full Text] [Related]
13. Syndecan-1 facilitates breast cancer metastasis to the brain.
Sayyad MR; Puchalapalli M; Vergara NG; Wangensteen SM; Moore M; Mu L; Edwards C; Anderson A; Kall S; Sullivan M; Dozmorov M; Singh J; Idowu MO; Koblinski JE
Breast Cancer Res Treat; 2019 Nov; 178(1):35-49. PubMed ID: 31327090
[TBL] [Abstract][Full Text] [Related]
14. CD138 (syndecan-1) expression in health and disease.
Palaiologou M; Delladetsima I; Tiniakos D
Histol Histopathol; 2014 Feb; 29(2):177-89. PubMed ID: 24150912
[TBL] [Abstract][Full Text] [Related]
15. Syndecan-1-Induced ECM Fiber Alignment Requires Integrin αvβ3 and Syndecan-1 Ectodomain and Heparan Sulfate Chains.
Yang N; Friedl A
PLoS One; 2016; 11(2):e0150132. PubMed ID: 26909794
[TBL] [Abstract][Full Text] [Related]
16. Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer.
Szarvas T; Reis H; Kramer G; Shariat SF; Vom Dorp F; Tschirdewahn S; Schmid KW; Kovalszky I; Rübben H
Hum Pathol; 2014 Apr; 45(4):674-82. PubMed ID: 24656090
[TBL] [Abstract][Full Text] [Related]
17. Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases.
Chute C; Yang X; Meyer K; Yang N; O'Neil K; Kasza I; Eliceiri K; Alexander C; Friedl A
Breast Cancer Res; 2018 Jul; 20(1):66. PubMed ID: 29976229
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow stromal cell interaction reduces syndecan-1 expression and induces kinomic changes in myeloma cells.
Fuhler GM; Baanstra M; Chesik D; Somasundaram R; Seckinger A; Hose D; Peppelenbosch MP; Bos NA
Exp Cell Res; 2010 Jul; 316(11):1816-28. PubMed ID: 20307537
[TBL] [Abstract][Full Text] [Related]
19. Glycobiology of syndecan-1 in bacterial infections.
Aquino RS; Teng YH; Park PW
Biochem Soc Trans; 2018 Apr; 46(2):371-377. PubMed ID: 29523771
[TBL] [Abstract][Full Text] [Related]
20. [Construction and identification of mouse wildtype-syndecan-1 and unshedding-syndecan-1 expressing vector].
Liu J; Wang JD; Kuang JS; Zhang SH; Tang YL; Wang ZQ; Qin HP; Chen Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):388-90. PubMed ID: 22482411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
